UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
NVR
NVR
$16.8B
| $4.21M | ﹤0.01% |
3,729
| – | – |
|
1027
Healthcare Realty
HR
$6.96B
| $4.19M | ﹤0.01% |
180,718
+2,350
| +1% | +$57K |
|
1028
Myriad Genetics
MYGN
$297M
| $4.14M | ﹤0.01% |
107,342
-2,600
| -2% | -$97K |
|
|
PL
1029
DELISTED
PROTECTIVE LIFE CORP
PL
| $4.12M | ﹤0.01% |
59,346
+1,200
| +2% | +$83.3K |
|
|
GRA
1030
DELISTED
W.R. Grace & Co.
GRA
| $4.1M | ﹤0.01% |
45,044
| – | – |
|
1031
Gerdau
GGB
$10.1B
| $4.09M | ﹤0.01% |
1,073,268
+74,718
| +7% | +$342K |
|
1032
Magnachip Semiconductor
MX
$144M
| $4.06M | ﹤0.01% |
347,098
-24,471
| -7% | -$320K |
|
1033
Gartner
IT
$11.6B
| $4.05M | ﹤0.01% |
55,159
| – | – |
|
|
HUB.B
1034
DELISTED
HUBBELL INC CL-B
HUB.B
| $4.02M | ﹤0.01% |
33,363
| – | – |
|
1035
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $4M | ﹤0.01% |
100,739
-865
| -0.9% | -$36K |
|
1036
Packaging Corp of America
PKG
$22.6B
| $3.99M | ﹤0.01% |
62,575
+1,300
| +2% | +$87.3K |
|
1037
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $3.97M | ﹤0.01% |
81,813
-30,000
| -27% | -$1.53M |
|
1038
Hope Bancorp
HOPE
$1.78B
| $3.95M | ﹤0.01% |
270,730
+3,142
| +1% | +$47.3K |
|
|
VIRX
1039
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.94M | ﹤0.01% |
2,629
-1,681
| -39% | -$2.43M |
|
|
WCC
1040
WESCO International
WCC
$18.2B
| $3.93M | ﹤0.01% |
50,245
| – | – |
|
1041
Banco de Chile
BCH
$21.3B
| $3.93M | ﹤0.01% |
174,876
+19
| +0% | +$436 |
|
1042
Broadridge
BR
$18.6B
| $3.9M | ﹤0.01% |
93,693
| – | – |
|
|
BRSL
1043
Brightstar Lottery PLC
BRSL
$1.99B
| $3.88M | ﹤0.01% |
230,023
-4,700
| -2% | -$78.2K |
|
1044
Alaska Air
ALK
$5.7B
| $3.88M | ﹤0.01% |
89,000
-3,680
| -4% | -$171K |
|
1045
Rigel Pharmaceuticals
RIGL
$726M
| $3.85M | ﹤0.01% |
198,640
+8,620
| +5% | +$244K |
|
|
WUBA
1046
DELISTED
58.com Inc
WUBA
| $3.85M | ﹤0.01% |
103,300
-34,400
| -25% | -$1.59M |
|
|
SZYM
1047
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $3.85M | ﹤0.01% |
515,398
-39,249
| -7% | -$367K |
|
1048
EPR Properties
EPR
$4.71B
| $3.84M | ﹤0.01% |
75,767
-2,900
| -4% | -$160K |
|
1049
Donaldson
DCI
$11.2B
| $3.82M | ﹤0.01% |
94,022
+7,150
| +8% | +$291K |
|
|
BDN
1050
Brandywine Realty Trust
BDN
$560M
| $3.78M | ﹤0.01% |
268,786
-116,400
| -30% | -$1.81M |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.